TG
ABMD

TCW Group’s Abiomed Inc ABMD Stock Holding History

TCW Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-8,422
Closed -$212K – 750
2014
Q2 		$212K Hold
8,422
– – ﹤0.01% 732
2014
Q1 		$220K Sell
8,422
-8,500
-50% -$235K ﹤0.01% 745
2013
Q4 		$453K Hold
16,922
– – ﹤0.01% 728
2013
Q3 		$322K Hold
16,922
– – ﹤0.01% 732
2013
Q2 		$364K Buy
+16,922
New +$340K ﹤0.01% 702

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

TCW Group's ABMD Position: Q3 2014 in Review

TCW Group sold out of Abiomed Inc (ABMD) in Q3 2014, closing a stake of 8,422 shares — an estimated $212K sold.

TCW Group first reported a position in ABMD in Q2 2013 and held it in 5 quarters. The position peaked at $453K in Q4 2013. 137 funds tracked by Wall St. Rank hold ABMD as of Q3 2014.

  • TCW Group reported no remaining Abiomed Inc position as of Q3 2014 after selling out during the quarter.
  • TCW Group sold 8,422 Abiomed Inc shares in Q3 2014, an estimated $212K.
  • TCW Group first reported a position in Abiomed Inc in Q2 2013 and held it in 5 quarters.
  • TCW Group's Abiomed Inc position peaked at $453K in Q4 2013.
  • 137 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2014.

Based on TCW Group's 13F filing for Q3 2014, filed 14 Nov 2014.